Disc Medicine, Inc.
IRON
$59.79
$0.3750.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 23.87% | 24.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 53.73% | 15.62% | |||
| Operating Income | -53.73% | -15.62% | |||
| Income Before Tax | -62.50% | -16.00% | |||
| Income Tax Expenses | -56.30% | -32.39% | |||
| Earnings from Continuing Operations | -62.09% | -15.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -62.09% | -15.71% | |||
| EBIT | -53.73% | -15.62% | |||
| EBITDA | -53.60% | -15.59% | |||
| EPS Basic | -54.22% | -4.14% | |||
| Normalized Basic EPS | -54.62% | -4.41% | |||
| EPS Diluted | -54.22% | -4.14% | |||
| Normalized Diluted EPS | -54.62% | -4.41% | |||
| Average Basic Shares Outstanding | 5.10% | 11.10% | |||
| Average Diluted Shares Outstanding | 5.10% | 11.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||